We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

POC Urinalysis Data Integrated into Electronic Medical Records

By LabMedica International staff writers
Posted on 26 Apr 2010
Flexible connectivity options have been introduced that will simplify point-of-care (POC) urine analysis--data is integrated into electronic medical records, directly to laboratory information systems, or via POC data management systems.

The connectivity options of the new system enhance testing oversight and streamline data management for hospital and physician-office based urine testing. The Clinitek Status Connect System is clinical laboratory improvement amendments (CLIA)-waived.

With the introduction of the new system, Siemens Healthcare (Erlangen, Germany) has expanded its POC urinalysis portfolio. The new features include barcode data entry; advanced operator management with operator lock-out to prevent unauthorized user access; quality control (QC) lock-out if quality controls fail or are not performed as programmed; and transmittal of operator name, patient ID, lot and expiration date with test results.

Siemens point-of-care data management system for urinalysis and blood gas testing, the RapidComm data management and connectivity solution, can also connect to the Clinitek Status Connect System, helping to streamline POC testing data further.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and is a leader in laboratory diagnostics, medical imaging, medical information technology, and hearing aids. Siemens offers products and solutions for the entire range of patient care from a single source--from prevention and early detection to diagnosis, and on to treatment and aftercare.

Related Links:

Siemens Healthcare



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
DNA Extraction Kit
MagMAX DNA Multi-Sample Ultra 2.0 Kit

Latest Clinical Chem. News

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
26 Apr 2010  |   Clinical Chem.

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
26 Apr 2010  |   Clinical Chem.

Low-Cost Portable Screening Test to Transform Kidney Disease Detection
26 Apr 2010  |   Clinical Chem.